Literature DB >> 17062661

Natural killer T cell-based cancer immunotherapy.

Hans J J van der Vliet1, Steven P Balk, Mark A Exley.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17062661     DOI： 10.1158/1078-0432.CCR-06-1392

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

Authors:  Weihua Song; Hans J J van der Vliet; Yu-Tzu Tai; Rao Prabhala; Ruojie Wang; Klaus Podar; Laurence Catley; Masood A Shammas; Kenneth C Anderson; Steven P Balk; Mark A Exley; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

2.  Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells.

Authors:  Hans J J van der Vliet; Ruojie Wang; Simon C Yue; Henry B Koon; Steven P Balk; Mark A Exley
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

3.  Development of a qPCR method to rapidly assess the function of NKT cells.

Authors:  Silke Sohn; Irina Tiper; Emily Japp; Wenji Sun; Katherine Tkaczuk; Tonya J Webb
Journal:  J Immunol Methods       Date:  2014-04-12       Impact factor: 2.303

4.  The effect of specific immunotherapy on natural killer T cells in peripheral blood of house dust mite-sensitized children with asthma.

Authors:  Lu Yan-ming; Cao Lan-fang; Li Chen; Li Ya-qin; Chen Wei; Zhang Wen-ming
Journal:  Clin Dev Immunol       Date:  2012-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.